GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wai Yuen Tong Medicine Holdings Ltd (HKSE:00897) » Definitions » Interest Expense

Wai Yuen Tong Medicine Holdings (HKSE:00897) Interest Expense : HK$-112 Mil (TTM As of Sep. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Wai Yuen Tong Medicine Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Wai Yuen Tong Medicine Holdings's interest expense for the six months ended in Sep. 2023 was HK$ -58 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2023 was HK$-112 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Wai Yuen Tong Medicine Holdings's Operating Income for the six months ended in Sep. 2023 was HK$ 67 Mil. Wai Yuen Tong Medicine Holdings's Interest Expense for the six months ended in Sep. 2023 was HK$ -58 Mil. Wai Yuen Tong Medicine Holdings's Interest Coverage for the quarter that ended in Sep. 2023 was 1.15. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Wai Yuen Tong Medicine Holdings Interest Expense Historical Data

The historical data trend for Wai Yuen Tong Medicine Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wai Yuen Tong Medicine Holdings Interest Expense Chart

Wai Yuen Tong Medicine Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -28.55 -52.78 -107.72 -95.70 -106.31

Wai Yuen Tong Medicine Holdings Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -47.88 -47.81 -52.45 -53.86 -57.79

Wai Yuen Tong Medicine Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-112 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wai Yuen Tong Medicine Holdings  (HKSE:00897) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Wai Yuen Tong Medicine Holdings's Interest Expense for the six months ended in Sep. 2023 was HK$-58 Mil. Its Operating Income for the six months ended in Sep. 2023 was HK$67 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Sep. 2023 was HK$878 Mil.

Wai Yuen Tong Medicine Holdings's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

Interest Coverage=-1* Operating Income (Q: Sep. 2023 )/Interest Expense (Q: Sep. 2023 )
=-1*66.683/-57.79
=1.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Wai Yuen Tong Medicine Holdings (HKSE:00897) Business Description

Traded in Other Exchanges
N/A
Address
39 Wang Kwong Road, Suite 3101, 31st Floor, Skyline Tower, Kowloon Bay, Kowloon, Hong Kong, HKG
Wai Yuen Tong Medicine Holdings Ltd is an investment holding company. The company's operating segment includes production and sale of Chinese pharmaceutical and health food products; production and sale of Western pharmaceutical and health food products and property investment and management and sale of properties in the agricultural produce market. It generates maximum revenue from the production and sale of Chinese pharmaceutical and health food products which include manufacturing, processing, and sale of traditional Chinese medicine which includes Chinese medicinal products sold under the brand name Wai Yuen Tong. Geographically, it derives a majority of revenue from Mainland China.
Executives
Wang On Group Limited 2501 Other
Tang Ching Ho 2501 Other
Yau Yuk Yin 2202 Interest of your spouse

Wai Yuen Tong Medicine Holdings (HKSE:00897) Headlines

No Headlines